Literature DB >> 9678705

Linkage disequilibrium between the M470V variant and the IVS8 polyT alleles of the CFTR gene in CBAVD.

A de Meeus1, C Guittard, M Desgeorges, S Carles, J Demaille, M Claustres.   

Abstract

Congenital bilateral absence of the vas deferens (CBAVD) is a cause of male sterility mostly resulting from mutations in the cystic fibrosis transmembrane regulator (CFTR) gene. The most common defect is the 5T variant at the branch/acceptor site of intron 8, which induces high levels of exon 9 skipping leading to non-functional protein. However, this 5T variant has incomplete penetrance and variable expressivity, suggesting that some other regulatory factors may modulate the splicing of exon 9. To identify such factors, we report here the genetic analysis of a polymorphic locus, M470V, located in exon 10 of the CFTR gene in 60 patients with CBAVD, compared to a normal control population. The statistical analysis showed strong linkage disequilibrium between the 5T allele and the V allele of the M470V polymorphism in the CBAVD population, but not in the normal population. The V allele in a gene carrying 5T could, however, contribute to lowering the level of normal transcripts, as already suggested by in vitro transcriptional studies. These genetic findings, together with previous studies, suggest involvement of the M470V variant in the modulation of the splicing of exon 9 of the CFTR gene.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9678705      PMCID: PMC1051371          DOI: 10.1136/jmg.35.7.594

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  10 in total

1.  A dimorphic 4-bp repeat in the cystic fibrosis gene is in absolute linkage disequilibrium with the delta F508 mutation: implications for prenatal diagnosis and mutation origin.

Authors:  F F Chehab; J Johnson; E Louie; M Goossens; E Kawasaki; H Erlich
Journal:  Am J Hum Genet       Date:  1991-02       Impact factor: 11.025

2.  Cystic fibrosis transmembrane conductance regulator and obstructive azoospermia.

Authors:  K Jarvi; J Zielenski; M Wilschanski; P Durie; M Buckspan; E Tullis; D Markiewicz; L C Tsui
Journal:  Lancet       Date:  1995-06-17       Impact factor: 79.321

3.  Increased proportion of exon 9 alternatively spliced CFTR transcripts in vas deferens compared with nasal epithelial cells.

Authors:  H Teng; M Jorissen; H Van Poppel; E Legius; J J Cassiman; H Cuppens
Journal:  Hum Mol Genet       Date:  1997-01       Impact factor: 6.150

4.  Identification of the cystic fibrosis gene: genetic analysis.

Authors:  B Kerem; J M Rommens; J A Buchanan; D Markiewicz; T K Cox; A Chakravarti; M Buchwald; L C Tsui
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

Review 5.  The molecular basis for disease variability in cystic fibrosis.

Authors:  B Kerem; E Kerem
Journal:  Eur J Hum Genet       Date:  1996       Impact factor: 4.246

6.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

7.  The molecular basis of partial penetrance of splicing mutations in cystic fibrosis.

Authors:  N Rave-Harel; E Kerem; M Nissim-Rafinia; I Madjar; R Goshen; A Augarten; A Rahat; A Hurwitz; A Darvasi; B Kerem
Journal:  Am J Hum Genet       Date:  1997-01       Impact factor: 11.025

8.  Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA.

Authors:  C S Chu; B C Trapnell; S Curristin; G R Cutting; R G Crystal
Journal:  Nat Genet       Date:  1993-02       Impact factor: 38.330

9.  Identification of the cystic fibrosis gene: chromosome walking and jumping.

Authors:  J M Rommens; M C Iannuzzi; B Kerem; M L Drumm; G Melmer; M Dean; R Rozmahel; J L Cole; D Kennedy; N Hidaka
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

10.  Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens.

Authors:  M Chillón; T Casals; B Mercier; L Bassas; W Lissens; S Silber; M C Romey; J Ruiz-Romero; C Verlingue; M Claustres
Journal:  N Engl J Med       Date:  1995-06-01       Impact factor: 91.245

  10 in total
  12 in total

1.  A haplotype framework for cystic fibrosis mutations in Iran.

Authors:  Elahe Elahi; Ahmad Khodadad; Ilya Kupershmidt; Fereshteh Ghasemi; Babak Alinasab; Ramin Naghizadeh; Robert G Eason; Mahshid Amini; Mehran Esmaili; Mohammad R Esmaeili Dooki; Mohammad H Sanati; Ronald W Davis; Mostafa Ronaghi; Yvonne R Thorstenson
Journal:  J Mol Diagn       Date:  2006-02       Impact factor: 5.568

2.  The relevance of sweat testing for the diagnosis of cystic fibrosis in the genomic era.

Authors:  Avantika Mishra; Ronda Greaves; John Massie
Journal:  Clin Biochem Rev       Date:  2005-11

3.  Association of cystic fibrosis transmembrane conductance regulator gene variants with acute lung injury in African American children with pneumonia*.

Authors:  Julie M Baughn; Michael W Quasney; Pippa Simpson; Daniel Merchant; Shun-Hwa Li; Hara Levy; Mary K Dahmer
Journal:  Crit Care Med       Date:  2012-11       Impact factor: 7.598

4.  Variation in a repeat sequence determines whether a common variant of the cystic fibrosis transmembrane conductance regulator gene is pathogenic or benign.

Authors:  Joshua D Groman; Timothy W Hefferon; Teresa Casals; Lluís Bassas; Xavier Estivill; Marie Des Georges; Caroline Guittard; Monika Koudova; M Daniele Fallin; Krisztina Nemeth; Gyorgy Fekete; Ludovit Kadasi; Ken Friedman; Martin Schwarz; Cristina Bombieri; Pier Franco Pignatti; Emmanuel Kanavakis; Maria Tzetis; Marianne Schwartz; Giuseppe Novelli; Maria Rosaria D'Apice; Agnieszka Sobczynska-Tomaszewska; Jerzy Bal; Manfred Stuhrmann; Milan Macek; Mireille Claustres; Garry R Cutting
Journal:  Am J Hum Genet       Date:  2003-12-18       Impact factor: 11.025

5.  The CFTR polymorphisms poly-T, TG-repeats and M470V in Chinese males with congenital bilateral absence of the vas deferens.

Authors:  Wu-Hua Ni; Lei Jiang; Qian-Jin Fei; Jian-Yuan Jin; Xu Yang; Xue-Feng Huang
Journal:  Asian J Androl       Date:  2012-07-30       Impact factor: 3.285

6.  The CFTR Met 470 allele is associated with lower birth rates in fertile men from a population isolate.

Authors:  Gülüm Kosova; Joseph K Pickrell; Joanna L Kelley; Patrick F McArdle; Alan R Shuldiner; Mark Abney; Carole Ober
Journal:  PLoS Genet       Date:  2010-06-03       Impact factor: 5.917

7.  Targeted sequencing reveals complex, phenotype-correlated genotypes in cystic fibrosis.

Authors:  Maxim Ivanov; Alina Matsvay; Olga Glazova; Stanislav Krasovskiy; Mariya Usacheva; Elena Amelina; Aleksandr Chernyak; Mikhail Ivanov; Sergey Musienko; Timofey Prodanov; Sergey Kovalenko; Ancha Baranova; Kamil Khafizov
Journal:  BMC Med Genomics       Date:  2018-02-13       Impact factor: 3.063

8.  The magnitude of ivacaftor effects on fluid secretion via R117H-CFTR channels: Human in vivo measurements.

Authors:  Jessica E Char; Colleen Dunn; Zoe Davies; Carlos Milla; Richard B Moss; Jeffrey J Wine
Journal:  PLoS One       Date:  2017-04-18       Impact factor: 3.240

9.  The CFTR M470V, intron 8 poly-T, and 8 TG-repeats detection in Chinese males with congenital bilateral absence of the vas deferens.

Authors:  Qiang Du; Zheng Li; Yongfeng Pan; Xiaoliang Liu; Bochen Pan; Bin Wu
Journal:  Biomed Res Int       Date:  2014-01-08       Impact factor: 3.411

10.  Meta-analyses of 4 CFTR variants associated with the risk of the congenital bilateral absence of the vas deferens.

Authors:  Xuting Xu; Jufen Zheng; Qi Liao; Huiqing Zhu; Hongyan Xie; Huijuan Shi; Shiwei Duan
Journal:  J Clin Bioinforma       Date:  2014-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.